Subscribe to Newsletter

Marketing

Business & Regulation Business Practice

Cast Out the Oracles

| Angus Stewart

Mike Rea of IDEA Pharma shares his thoughts on what players in pharma positioning are getting right – and wrong.

Business & Regulation Business Practice

Seriously Y'all Stop It

| Stephanie Vine

Pharma wants to empower patients to make informed healthcare decisions, but patients also need to be protected from misinformation.

Business & Regulation Biosimilars

What Lies Ahead for Biosimilars?

| Stephanie Vine

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.

Business & Regulation COVID-19

Where Did it All Go Wrong for AstraZeneca?

| James Strachan

How did AstraZeneca end up in a PR nightmare?

Business & Regulation Business Practice

The Great Rebrander

| Maryam Mahdi

What makes pharma so good at rebranding?

Business & Regulation Business Practice

The Next Great Recession

| George A. Chressanthis

Is the pharma industry ready for another recession?

Business & Regulation Business Practice

How to Commercialize an Orphan Drug

| George A. Chressanthis, Animesh Arun

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Business & Regulation Business Practice

Business-in-Brief

| Stephanie Vine

Mega mergers, state-of-the-art stem cell facility and humorous pharmaceutical ads… What’s new for pharma in business?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register